In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres

International Journal of Antimicrobial Agents

Volumn 15, Issue 3, 2000, Pages 213-219

  Blondeau, J M ^a   Vaughan, D ^b  

^a Saskatoon Dist Hlth St Paul's H   (Canada)

^b Anti Infective Division   (Canada)

Author keywords

Antimicrobial agents; Canadian medical centres; In vitro activity; Nosocomial pathogens

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CARBENICILLIN; CEFAMANDOLE; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTETAN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; IMIPENEM; MEZLOCILLIN; NETILMICIN; SULTAMICILLIN; TICARCILLIN; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANADA; CITROBACTER; DRUG COST; DRUG USE; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; KLEBSIELLA; MORAXELLA; MORGANELLA; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; SERRATIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

CANADA; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; URINARY TRACT INFECTIONS;

EID: 0033841449     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00170-9     Document Type: Article

References (21)

1. Schaberg D.R. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):1991;72S-75S.
2. Kunin C.M. Resistance to antimicrobial drugs - a world wide calamity. Ann. Int. Med. 118:1993;557-561.
3. Levy SB. The challenge of antibiotic resistance. Sci Am 1998;March:46-53.
4. Blondeau J.M., Yaschuk Y. Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Antimicrob. Agents Chemother. 40:1996;1729-1732.
5. Blondeau J.M., Yaschuk Y. Canadian multicenter susceptibility study, with a focus on cephalosporins, from 15 Canadian medical centers. Antimicrob. Agents Chemother. 41:1997;2773-2775.
6. National Committee for Clinical Laboratory Standards. Approved Standard M7-A2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. National Committee for Clinical Laboratory Standards, Villanova, PA, 1993.
7. Blondeau JM, Shiplett ME, The Canadian Study Group. Canadian Pseudomonas aeruginosa susceptibility study: a comparative study from 55 Canadian centers. 35th Intersci Conf on Antimicrobial Agents and Chemotherapy, San Francisco, CA, Abstract #E127, 1995.
8. Forward K.R., Low D.E., Laverdiere M., Rennie R., Simor A.E., Franks P.A. Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates. Can. J. Infect. Dis. 8:1997;147-153.
9. Kanchana MV, McClean K, Hanson G, Beaudry Y, Knight I, Blondeau JM. VRE - It's Not Here! - Oh! Now It's Here: The vancomycin resistant enterococcus (VRE) outbreak in Saskatoon. 64th Conjoint Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, Hamilton, Ont., Canada, Abstract #PS-81, 1996.
10. Lior LY, Litt M, Hockin J et al. Vancomycin-resistant Enterococci arrives in Canada: a case-control analysis of 'The Call Bell' outbreak. 36th Intersci Conf on Antimicrobial Agents and Chemotherapy, New Orleans, LA, Abstract #C15, 1996.
11. Results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can. Comm. Dis. Rep. 23:1997;41-46.
12. Mazzulli T., Simor A.E., Jaeger R., Fuller S., Low D.E. Comparative in vitro activities of several new fluoroquinolones and β-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 34:1990;467-469.
13. Simor A.E., Louie M., Low D.E. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:1996;2190-2193.
14. Blondeau JM, Vaughan D, Low D, Graham C, Suter M. Regional resistance rates for penicillin resistant Streptococcus pneumoniae (PRSP) in Saskatchewan, Canada. 20th Int Congr of Chemotherapy, Sydney, Australia, Abstract #P008-3209, 1997.
15. Blondeau JM, Vaughan D, Laskowski R, Bjarnason. Antimicrobial resistance amongst respiratory tract pathogens from adults and children: a Canadian multicenter study. 37th Intersci Conf on Antimicrobial Agents and Chemotherapy, Toronto, Ont., Canada, Abstract #E-56, 1997.
16. Chamberland S., L'Ecuyer J., Lessard C., Bernier M., Rovencher P, Bergeron M. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolates from septicemia patients throughout Canada. Clin. Infect. Dis. 15:1992;615-628.
17. Toye B.W., Scriver S.R., Low D.E. Canadian survey of antimicrobial resistance in Klebsiella species. J. Antimicrob. Chemother. 32(Suppl. B):1993;81-86.
18. Forward KR, Franks P, Low DE, Laverdiere M, Rennie R, Simor AE. A cross Canada survey of resistance to piperacillin/tazobactam and other antibiotics against 2747 aerobic blood culture isolates. 36th Intersci Conf on Antimicrobial Agents and Chemotherapy, New Orleans, LA, Abstract #E14, 1996.
19. Coronado V.G., Edwards J.R., Culver D.H., Gaynes R.P. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect. Control Hosp. Epidemiol. 16:1995;71-75.
20. Hoban D.J., Jones R.N. Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Chemotherapy. 41:1995;34-38.
21. Jones R.N., Pfaller M.A., Marshall S.A., Hollis R.J., Wilke W.W. Antimicrobial activity of 12 broad spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn. Microbiol. Infect. Dis. 29:1997;187-192.